Hepatitis C virus NS3/4A protease blocks IL-28 production

Area of Science:

• Immunology
• Virology
• Molecular Biology

Background:

• Type I interferons (IFNs) are crucial for antiviral immunity.
• Type III IFNs (IFN-λ) are a newly identified subfamily with antiviral properties.
• Mechanisms regulating type III IFN induction during viral infections are not fully understood.

Purpose of the Study:

• To investigate the induction of type III IFNs (specifically IL-28, also known as IFN-λ 2/3) in response to Hepatitis C virus (HCV) genomic RNA.
• To elucidate the molecular mechanisms controlling IL-28 expression during HCV infection.
• To understand how HCV infection modulates the type III IFN response.

Main Methods:

• Transfection of cells with HCV genomic RNA.
• Analysis of IL-28 promoter activity and transcription factor binding sites (NF-κB and IRF3).
• Assessment of viral protease activity (NS3/4A) in modulating IL-28 expression.

Main Results:

• IL-28 production is a direct host response to HCV genomic RNA transfection.
• IL-28 induction relies on the activation of NF-κB and IRF3 transcription factors.
• HCV infection inhibits IL-28 expression, mediated by the NS3/4A protease.

Conclusions:

• HCV actively controls type III IFN (IL-28) response.
• The viral NS3/4A protease plays a significant role in evading host antiviral immunity.
• Understanding these mechanisms provides insights into HCV persistence.